CG
NAUT icon

Caprock Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Caprock Group’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$171K Hold
44,090
– – ﹤0.01% 1060
2025
Q4 		$86K Buy
44,090
+27,000
+158% +$44.3K ﹤0.01% 1162
2025
Q3 		$11.6K Buy
+17,090
New +$12.6K ﹤0.01% 1121
2025
Q1 		$8.69K Buy
+10,090
New +$15K ﹤0.01% 1074
2022
Q2 		– Sell
-24,790
Closed -$108K – 607
2022
Q1 		$108K Buy
+24,790
New +$102K 0.01% 590

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Caprock Group's NAUT Position: Q1 2026 in Review

Caprock Group held its Nautilus Biotechnolgy (NAUT) position steady in Q1 2026 at 44,090 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

Caprock Group first reported a position in NAUT in Q1 2022 and has held it in 5 quarters since. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Caprock Group held 44,090 shares of Nautilus Biotechnolgy worth $171K as of Q1 2026.
  • Caprock Group left its Nautilus Biotechnolgy share count unchanged in Q1 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Caprock Group's portfolio in Q1 2026, its #1060 holding.
  • Caprock Group first reported a position in Nautilus Biotechnolgy in Q1 2022 and has held it in 5 quarters since.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.